INS and metabolic dysfunction-associated steatotic liver disease: Additionally, an experimental study on NAFLD mice model demonstrated that chronic administration of MK is able to reduce insulin levels, liver fat deposits, and obesity‐related parameters thereby reducing NAFLD progression [34, 36].